AlphAIAlphAI — Financial news for AI agents
investing.comOCT 271 min read$VTR

Ventas earnings missed by $0.03, revenue topped estimates

Ventas (VTR) reported Q3 EPS of $0.13, missing estimates by $0.03, while revenue of $1.83B exceeded expectations. The stock is down 10.88% over 3 months but up 18.97% year-over-year. InvestingPro rates its financial health as 'good performance'.

Original reporting
investing.com
Published Oct 27, 2026, 8:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$VTR
Bearish
high confidence
Mentioned
$VTR
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$VTRBearishMed
01

Why it matters

The modest EPS miss may trigger short‑term selling pressure, though the revenue beat offers a counterpoint.

02

Market read

Earnings release provides fresh data for traders; the miss could affect short‑term price action.

03

What to watch

Guidance outlook and balance‑sheet health were not discussed, which may mitigate the EPS miss.

Relevance 7/10Novelty 8/10Timing: after-hours reaction

Background

Ventas (NYSE: VTR) is a health‑care focused REIT that released its Q3 earnings.

Company-level read

Ticker impact

$VTRBearishHigh confidence
Context

Ventas reported Q3 EPS of $0.13, missing estimates by $0.03 and revenue of $1.83B versus $1.77B consensus.

Expected impact

likely downside as investors price in the EPS miss

Evidence & confidence

The miss is modest but below expectations; market typically reacts negatively to any EPS shortfall.

Market effects

Sector

REIT sector may see slight pressure as earnings miss highlights valuation concerns.

Regional

U.S. market, primarily affecting health‑care REITs.

Global

Limited to U.S. REIT investors.

Counterpoint

What could challenge this read

The revenue beat could support a bounce if investors focus on top‑line strength.

Key entities

  • Company
    Ventas

    Health‑care REIT reporting Q3 results.

Read at source← All news

StoryVentas reports Q3 2026 results, raises full‑year FFO guidance despite EPS miss

Also covered by

3 outlets

Related articles

OCT 28
$VTRHighAI 8/10

Ventas Q3 2026 slides show strong operations, raised guidance post-EPS miss

Ventas Inc. (VTR) reported Q3 2026 earnings with normalized FFO of $0.99 per share, a 10% YoY increase, but missed EPS estimates by $0.03. Revenue exceeded forecasts by $60 million. The company raised full-year FFO guidance to $3.87-$3.90 per share. Shares fell 4.03% to $79.98 post-earnings. Ventas highlighted strong operational metrics, including 11% total same-store cash NOI growth and 17% U.S. SHOP same-store cash NOI growth.

investing.com2 min
OCT 27
$VTRHigh

Ventas Reports 2026 Third Quarter Results

Ventas, Inc. (VTR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ventas, Inc. 300 North LaSalle Street, Suite 1600 Chicago, Illinois 60654 (877) 4-VENTAS www.ventasreit.com Contact: BJ Grant (877) 4-VENTAS Ventas Reports 2026 Third Quarter Results CHICAGO – Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported result

SEC EDGAR 8-K2 min
OCT 27
$VTRHighAI 8/10

After $5.2 billion in senior housing investments this year, Ventas raised its 2026 earnings outlook.

Ventas, Inc. (VTR) reported strong Q3 2026 results, with 10% year-over-year growth in Normalized FFO per share and 18% growth in Total Company Net Operating Income. The company has invested $5.2 billion in senior housing this year and raised its 2026 earnings outlook due to accretive investments, partially offset by interest rates and foreign exchange impacts. Ventas's CEO highlighted the company's outperformance and growth strategy.

stocktitan.net2 min
OCT 13
$VTRMed

Ventas (VTR) Targets Up to 17% NOI Growth and Expands Acquisition Budget to $3 Billion

Ventas (VTR) targets 15-17% NOI growth and expands its acquisition budget to $3 billion, according to Guinness Global Real Assets Fund's Q3 2026 investor letter. The healthcare REIT's stock has traded between $67.36 and $101.60 over the past 52 weeks, closing at $83.54 on October 12, 2026, with a market cap of $43.11 billion. The fund notes potential benefits from improving senior housing occupancy and limited new supply.

finance.yahoo.com4 min
SEP 30
$WELLMedAI 8/10

The Senior Housing Boom Is Here. These 5 REITs Are Paying Investors to Ride It

Five senior housing REITs raised dividends in 2026, driven by strong demand. Welltower (WELL) and Ventas (VTR) lead in operating exposure, while Omega (OHI) and CareTrust (CTRE) focus on tenant credit and coverage. Dividend yields and coverage ratios vary, with Welltower offering the deepest buffer. Growth is fueled by acquisitions and equity raising, but risks include integration and operator stability.

247wallst.com3 min